CIK 0001285550 · Non-accelerated filer<br>Smaller reporting company
ClearPoint Neuro, Inc.
Sign in to watch- Ticker
- CLPT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582394628
- Phone
- 9499006833
- Business address
- 120 S. SIERRA AVENUE, SUITE 100, SOLANA BEACH, CA, 92075
- Former names
- MRI INTERVENTIONS, INC., SURGIVISION INC, SURGI VISION INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-06 | SABRA MAZIN Chief Operating Officer | Grant or award · Stock Options (right to buy) | +11,522 | 11,522 | ||
| 2023-03-06 | SABRA MAZIN Chief Operating Officer | Grant or award · Restricted Stock Units | +34,567 | 34,567 | ||
| 2023-02-22 | STIGALL L. JEREMY GM, Biologics & Drug Delivery | Shares withheld for taxes | −514 | $8.55 | $4K | 42,906 |
| 2023-01-03 | Richards Timothy T. Director | Grant or award | +1,399 | $7.97 | $11K | 36,038 |
| 2023-01-03 | Girin Pascal E R Director | Grant or award | +901 | $7.97 | $7K | 49,653 |
| 2023-01-03 | FLETCHER R JOHN Director | Grant or award | +2,175 | $7.97 | $17K | 70,461 |
| 2023-01-03 | JOHNSON B KRISTINE Director | Grant or award | +431 | $7.97 | $3K | 20,453 |
| 2022-10-10 | SABRA MAZIN Chief Operating Officer | Grant or award | +46,000 | 46,900 | ||
| 2022-10-03 | Richards Timothy T. Director | Grant or award | +1,094 | $10.19 | $11K | 34,639 |
| 2022-10-03 | FLETCHER R JOHN Director | Grant or award | +1,702 | $10.19 | $17K | 68,286 |
| 2022-10-03 | Girin Pascal E R Director | Grant or award | +705 | $10.19 | $7K | 48,752 |
| 2022-10-03 | JOHNSON B KRISTINE Director | Grant or award | +337 | $10.19 | $3K | 20,022 |
| 2022-09-29 | D'Alessandro Danilo Chief Financial Officer | Shares withheld for taxes | −4,958 | $10.23 | $51K | 53,477 |
| 2022-08-20 | BURNETT JOSEPH MICHAEL CEO and President | Shares withheld for taxes | −1,457 | $13.24 | $19K | 260,638 |
| 2022-08-20 | STIGALL L. JEREMY GM, Biologics & Drug Delivery | Shares withheld for taxes | −203 | $13.24 | $3K | 42,692 |
| 2022-08-20 | D'Alessandro Danilo Chief Financial Officer | Shares withheld for taxes | −583 | $13.24 | $8K | 58,435 |
| 2022-08-15 | BURNETT JOSEPH MICHAEL CEO and President | Shares withheld for taxes | −7,778 | $16.02 | $125K | 280,962 |
| 2022-08-15 | BURNETT JOSEPH MICHAEL CEO and President | Sale | −18,867 | $16.07 | $303K | 262,095 |
| 2022-07-09 | BURNETT JOSEPH MICHAEL CEO and President | Shares withheld for taxes | −6,664 | $14.24 | $95K | 286,585 |
| 2022-07-06 | STIGALL L. JEREMY GM, Biologics & Drug Delivery | Shares withheld for taxes | −1,685 | $13.87 | $23K | 41,526 |
Page 16 of 22 · 433 trades